For example, the FDA said about 20% of the bioreactor ... Sanofi (NYSE: SNY) acquired the Framingham facility when it bought Massachusetts-based Genzyme in a deal worth over $20 billion in 2011.

The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.

Maura Healey expanded Massachusetts' gun laws to include ... ghost guns often go hand-in-hand with those involved in drug distribution. Framingham police allege that is the case in last week's ...

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. drug ingredients plant tied to its longstanding subsidiary Genzyme.

The Food and Drug Administration has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility in Massachusetts where the company makes ...

23—THURSDAY, Jan. 23, 2025 (HealthDay News) — The U.S. Food and Drug Administration has ... at their Genzyme manufacturing plant in Framingham, Massachusetts. On Jan. 15, 2025, a warning ...